Literature DB >> 10934108

The Fas/Fas-ligand system is not required for bleomycin-induced pulmonary fibrosis in mice.

K Aoshiba1, S Yasui, J Tamaoki, A Nagai.   

Abstract

Recent studies suggest that Fas-Fas-ligand (FasL) interactions play an important role in the development of lung injury and fibrosis. However, evidence to support this concept is still indirect. To determine whether Fas-FasL interaction is required for the development of bleomycin-induced pulmonary fibrosis in mice, we used Fas-deficient (lpr) and FasL-deficient (gld ) mice as animal models. After intratracheal instillation of bleomycin, we examined the lungs of mice through bronchoalveolar lavage, histologic studies, DNA nick-end labeling, and hydroxyproline assay. The development of cellular infiltrates, bronchiolar and alveolar epithelial apoptosis, and fibrosis following bleomycin instillation in the lungs in lpr mice and gld mice was similar to their development in wild-type mice. The results of this study show that bleomycin-induced pulmonary fibrosis does not require Fas-FasL interaction, and that epithelial cell apoptosis after bleomycin exposure is mediated by Fas-independent pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10934108     DOI: 10.1164/ajrccm.162.2.9907012

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  13 in total

Review 1.  Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Treat Respir Med       Date:  2006

Review 2.  Epithelial-mesenchymal interactions in pulmonary fibrosis.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Semin Respir Crit Care Med       Date:  2006-12       Impact factor: 3.119

Review 3.  Myofibroblast differentiation and survival in fibrotic disease.

Authors:  Kornelia Kis; Xiaoqiu Liu; James S Hagood
Journal:  Expert Rev Mol Med       Date:  2011-08-23       Impact factor: 5.600

4.  Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans.

Authors:  Fengrong Zuo; Naftali Kaminski; Elsie Eugui; John Allard; Zohar Yakhini; Amir Ben-Dor; Lance Lollini; David Morris; Yong Kim; Barbara DeLustro; Dean Sheppard; Annie Pardo; Moises Selman; Renu A Heller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

5.  CD40-CD40 ligand disruption does not prevent hyperoxia-induced injury.

Authors:  Constance Barazzone Argiroffo; Yves R Donati; Julien Boccard; Anne F Rochat; Christian Vesin; Chen-Da Kan; Pierre-François Piguet
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

6.  Bleomycin induces the extrinsic apoptotic pathway in pulmonary endothelial cells.

Authors:  Ognoon Mungunsukh; Autumn J Griffin; Young H Lee; Regina M Day
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-02-12       Impact factor: 5.464

7.  Oxidative processing of latent Fas in the endoplasmic reticulum controls the strength of apoptosis.

Authors:  Vikas Anathy; Elle Roberson; Brian Cunniff; James D Nolin; Sidra Hoffman; Page Spiess; Amy S Guala; Karolyn G Lahue; Dylan Goldman; Stevenson Flemer; Albert van der Vliet; Nicholas H Heintz; Ralph C Budd; Kenneth D Tew; Yvonne M W Janssen-Heininger
Journal:  Mol Cell Biol       Date:  2012-07-02       Impact factor: 4.272

8.  Differential role of the Fas/Fas ligand apoptotic pathway in inflammation and lung fibrosis associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia and acute respiratory distress syndrome.

Authors:  Andrea D Lopez; Sreedevi Avasarala; Suman Grewal; Anuradha K Murali; Lucille London
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

9.  Proapoptotic Bid is required for pulmonary fibrosis.

Authors:  G R Scott Budinger; Gökhan M Mutlu; James Eisenbart; Alyson C Fuller; Amy A Bellmeyer; Christina M Baker; Mindy Wilson; Karen Ridge; Terrence A Barrett; Vivian Y Lee; Navdeep S Chandel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

Review 10.  Growth factors in idiopathic pulmonary fibrosis: relative roles.

Authors:  Jeremy T Allen; Monica A Spiteri
Journal:  Respir Res       Date:  2001-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.